Home > Share Market > Stocks > Balaxi pharmaceuticals > Financial Statements > BALAXI Key Financial Ratios

Balaxi pharmaceuticals Financial Statements

Balaxi pharmaceuticals Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2019
Growth matrix (%)        
Revenue growth 20.80 407 236 --
Op profit growth 18.40 599 290 --
EBIT growth 23.30 400 264 --
Net profit growth 25 525 210 --
Profitability ratios (%)        
OPM 18 18.30 13.30 11.40
EBIT margin 19.60 19.20 19.40 17.90
Net profit margin 17.10 16.50 13.40 14.50
RoCE 58.90 92 56.80 --
RoNW 13.40 20.60 9.76 --
RoA 12.80 19.80 9.77 --
Per share ratios ()        
EPS 47.70 38.10 6.10 6.47
Dividend per share -- -- -- --
Cash EPS 47.10 37.80 6.10 6.46
Book value per share 113 65 27.80 11.60
Valuation ratios        
P/E 7.38 13.80 12.10 5.87
P/CEPS 7.46 13.90 12.10 5.89
P/B 3.11 8.07 2.67 3.28
EV/EBIDTA 6.31 11.80 7.88 4.67
Payout (%)        
Dividend payout -- -- -- --
Tax payout (13) (14) (31) (19)
Liquidity ratios        
Debtor days 68.80 84 141 --
Inventory days 73.40 11.40 3.32 --
Creditor days (61) (30) (36) --
Leverage ratios        
Interest coverage (386) (3,385) -- --
Net debt / equity -- 0.03 (0.10) --
Net debt / op. profit (0.10) 0.05 (0.70) (0.10)
Cost breakup ()        
Material costs (70) (74) (74) (75)
Employee costs (4.50) (3.70) (4.60) (6.60)
Other costs (7.60) (3.60) (8.50) (6.60)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000